Cancer Prevention and Therapy in a Preclinical Mouse Model: Impact of FHIT Viruses
Journal:
Current Gene Therapy
Volume:
4
Page:
53-63
Author(s):
Hideshi Ishii, Andrea Vecchione, Louise Y.Y. Fong, Nicola Zanesi, Francesco Trapasso, Yusuke Furukawa, Raffaele Baffa, Kay Huebner and Carlo M. Croce
NSAIDs and Chemoprevention
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
29-42
Author(s):
Chinthalapally V. Rao and Bandaru S. Reddy
Death Receptors as Targets of Cancer Therapeutics
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
97-104
Author(s):
M. Saeed Sheikh and Ying Huang
Subject Index to Volume 9
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
89-108
Author(s):
Bentham Science Publishers
Pharmacogenetics of Estrogen Metabolism and Transport in Relation to Cancer
Journal:
Current Drug Metabolism
Volume:
4
Page:
505-513
Author(s):
Nehal J. Lakhani, Jurgen Venitz, William D. Figg and Alex Sparreboom
The Role of Apoptosis in Tumor Progression and Metastasis
Journal:
Current Molecular Medicine
Volume:
3
Page:
631-642
Author(s):
Jason L. Townson, George N. Naumov and Ann F. Chambers
Preface [Hot topic: Implications of COX-2 Inhibition in the Gastrointestinal Tract (Executive Editor : Angel Lanas)]
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
ii-ii
Author(s):
Angel Lanas
Cyclooxygenase-2 Biology
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
2177-2190
Author(s):
Joan Claria
COX-2 Inhibition in Esophagitis, Barretts Esophagus and Esophageal Cancer
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
2267-2280
Author(s):
E. Piazuelo, P. Jimenez and A. Lanas
Mechanisms of Viral Hepatitis Induced Liver Injury
Journal:
Current Molecular Medicine
Volume:
3
Page:
537-544
Author(s):
Yasunari Nakamoto and Shuichi Kaneko